Probable Vogt–Koyanagi–Harada disease with initial unilateral ocular manifestation in a hepatitis C carrier

Rao NA (2007) Pathology of Vogt–Koyanagi–Harada disease. Int Ophthalmol 27(2–3):81–85 Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M (2001) Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647–652 Usui Y, Goto H, Sakai J, Takeuchi M, Usui M, Rao NA (2009) Presumed Vogt–Koyanagi–Harada disease with unilateral ocular involvement: report of three cases. Graefes Arch Clin Exp Ophthalmol 247(8):1127–1132 Bordaberry MF (2010) Vogt–Koyanagi–Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol 21(6):430–435 Touitou V, Bodaghi B, Cassoux N, Tran TH, Rao NA, Cacoub P, LeHoang P (2005) Vogt–Koyanagi–Harada disease in patients with chronic hepatitis C. Am J Ophthalmol 140(5):949–952 Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK (2011) Vogt–Koyanagi–Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. Korean J Hepatol 17(1):61–65. doi:10.3350/kjhep.2011.17.1.61 Sene D, Touitou V, Bodaghi B, Saadoun D, Perlemuter G, Cassoux N, Piette JC, Hoang PL, Cacoub P (2007) Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C. World J Gastroenterol 13(22):3137–3140